A variety of factors in the tumor microenvironment, such as hypoxia (18) and certain metabolites (19), can regulate the hydroxylase activity of PHD2 to restrain HIF-1α degradation, resulting in augmented HIF-1α protein levels and elevated aerobic glycolysis in cancer cells (20). Here, HIF1A is linked to cancer.